| 000 | 01805 a2200613 4500 | ||
|---|---|---|---|
| 005 | 20250516052330.0 | ||
| 264 | 0 | _c20111027 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e31822c9135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEngelter, S T | |
| 245 | 0 | 0 |
_aIV thrombolysis and statins. _h[electronic resource] |
| 260 |
_bNeurology _cAug 2011 |
||
| 300 |
_a888-95 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aIntracranial Hemorrhages _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSoinne, L | |
| 700 | 1 | _aRingleb, P | |
| 700 | 1 | _aSarikaya, H | |
| 700 | 1 | _aBordet, R | |
| 700 | 1 | _aBerrouschot, J | |
| 700 | 1 | _aOdier, C | |
| 700 | 1 | _aArnold, M | |
| 700 | 1 | _aFord, G A | |
| 700 | 1 | _aPezzini, A | |
| 700 | 1 | _aZini, A | |
| 700 | 1 | _aRantanen, K | |
| 700 | 1 | _aRocco, A | |
| 700 | 1 | _aBonati, L H | |
| 700 | 1 | _aKellert, L | |
| 700 | 1 | _aStrbian, D | |
| 700 | 1 | _aStoll, A | |
| 700 | 1 | _aMeier, N | |
| 700 | 1 | _aMichel, P | |
| 700 | 1 | _aBaumgartner, R W | |
| 700 | 1 | _aLeys, D | |
| 700 | 1 | _aTatlisumak, T | |
| 700 | 1 | _aLyrer, P A | |
| 773 | 0 |
_tNeurology _gvol. 77 _gno. 9 _gp. 888-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e31822c9135 _zAvailable from publisher's website |
| 999 |
_c21093224 _d21093224 |
||